Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-25 (Hyzetimibe) +/- Atorvastatin in Primary Hypercholesterolemia
NCT03464682Phase 3Unknown
- Sponsor
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Start
- Feb 2015
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of hybutimibe in hypercholesterolemia, sponsored by Zhejiang Hisun Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
hybutimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT03464682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03464682.